- Nano cap Regulus Therapeutics (RGLS +20%) is up on average volume. The jump in buying is being stoked by the disclosure that Chairman Stelios Papadopoulos recently acquired a 500K stake at an average price of ~$1.22.
- The company's pipeline consists of HCV candidate RG-101, Alport syndrome candidate RG-012, diabetes candidate RG-125 and kidney disease candidate RGLS4326.
Regulus perks up 20% on Chairman's stock purchase
Recommended For You
About RGLS Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
RGLS | - | - |
Regulus Therapeutics Inc. |